Overview

• Current vaccines are in short supply as pharmacies await updated versions.
• New vaccines from Pfizer, Moderna, and Novavax will target the KP.2 strain and its variants.
• Experts recommend high-risk individuals get vaccinated as soon as the new shots are available.
• Timing of vaccination is crucial for optimal protection through the winter season.
• Costs for the new vaccines will be covered by most insurance plans, but uninsured adults may face challenges.